BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11996828)

  • 1. Characterization of human nasal primary culture systems to investigate peptide metabolism.
    Hoang VD; Uchenna AR; Mark J; Renaat K; Norbert V
    Int J Pharm; 2002 May; 238(1-2):247-56. PubMed ID: 11996828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmucosal delivery of leucine enkephalin: stabilization in rabbit enzyme extracts and enhancement of permeation through mucosae.
    Sayani AP; Chun IK; Chien YW
    J Pharm Sci; 1993 Nov; 82(11):1179-85. PubMed ID: 8289138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery.
    Cros CD; Toth I; Blanchfield JT
    Bioorg Med Chem; 2011 Feb; 19(4):1528-34. PubMed ID: 21273080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of leucine enkephalin in the nasal cavity of the rat--a possible factor in the low bioavailability of nasally administered peptides.
    Hussain A; Faraj J; Aramaki Y; Truelove JE
    Biochem Biophys Res Commun; 1985 Dec; 133(3):923-8. PubMed ID: 4084310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium.
    Agu RU; Vu Dang H; Jorissen M; Willems T; Kinget R; Verbeke N
    Int J Pharm; 2002 Apr; 237(1-2):179-91. PubMed ID: 11955816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of nasal absorption of drugs. III: Nasal absorption of leucine enkephalin.
    Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
    J Pharm Sci; 1990 Aug; 79(8):698-702. PubMed ID: 2231332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of leucine-enkephalin in rat brain by a new high-performance liquid chromatographic method.
    Mahy N; Tusell JM; Gelpi E
    J Chromatogr; 1982 Dec; 233():115-22. PubMed ID: 7161327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmucosal delivery of methionine enkephalin. I: Solution stability and kinetics of degradation in various rabbit mucosa extracts.
    Chun IK; Chien YW
    J Pharm Sci; 1993 Apr; 82(4):373-8. PubMed ID: 8468681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.
    Hussain MA; Shenvi AB; Rowe SM; Shefter E
    Pharm Res; 1989 Feb; 6(2):186-9. PubMed ID: 2788271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel distribution of methionine-enkephalin-Arg6-Gly7-Leu8 with methionine-enkephalin, leucine-enkephalin and methionine-enkephalin-Arg6-Phe7 in human and bovine brains.
    Ikeda Y; Nakao K; Yoshimasa T; Sakamoto M; Suda M; Yanaihara N; Imura H
    Life Sci; 1983; 33 Suppl 1():65-8. PubMed ID: 6664241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a neutral endopeptidase activity in Aplysia californica.
    Bawab W; Aloyz RS; Crine P; Roques BP; DesGroseillers L
    Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):459-65. PubMed ID: 8257438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
    Shibanoki S; Weinberger SB; Beniston D; Nudelman KA; Schulteis G; Bennett EL; Rosenzweig MR; Ishikawa K; Martinez JL
    J Pharmacol Exp Ther; 1991 Feb; 256(2):650-5. PubMed ID: 1994000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.
    Uchiyama T; Kotani A; Kishida T; Tatsumi H; Okamoto A; Fujita T; Murakami M; Muranishi S; Yamamoto A
    J Pharm Sci; 1998 Apr; 87(4):448-52. PubMed ID: 9548897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Leu-enkephalin degradation by a soluble enzyme preparation from calf-brain striatum using reversed-phase high-performance liquid chromatography.
    van Amsterdam JG; van Buuren KJ; Dik J; Wynne HJ
    J Chromatogr; 1983 Mar; 258():165-74. PubMed ID: 6841525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
    Hussain MA; Koval CA; Shenvi AB; Aungst BJ
    J Pharm Sci; 1990 May; 79(5):398-400. PubMed ID: 2352157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin.
    Bernkop-Schnürch A; Obermair K; Greimel A; Palmberger TF
    Amino Acids; 2006 Jun; 30(4):417-23. PubMed ID: 16554973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium.
    Agu RU; Vu Dang H; Jorissen M; Kinget R; Verbeke N
    Peptides; 2004 Apr; 25(4):563-9. PubMed ID: 15165710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.